【感染症分野】

Exocyst complex component 2 is a potential host factor for SARS-CoV-2 infection.　Yi R, Hashimoto R, Sakamoto A, Matsumura Y, Nagao M, Takahashi K, Takayama K. iScience, 2022; 25: 11-105427

Comparison of six antibody assays and two combination assays for COVID-19.　Yamamoto M, Okazaki K, Kitai Y, Shinohara K, Yukawa S, Noguchi T, Tanaka M, Matsumura Y, Nishiyama Y, Nagao M. Virol J, 2022; 19:1-24

Cervical abscess caused by Mycobacterium tilburgii in a patient carrying anti-interferon gamma autoantibody: A case report and literature review. Shinohara K, Matsumura Y, Sakagami T, Morioka S, Yoshizawa K, Aoki K, Motobayashi H, Tochitani K, Nagao M, Shimizu T. J Infect Chemother, 2022; 28: 5 699-704

Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020-June 2021. Matsumura Y, Nagao M, Yamamoto M, Tsuchido Y, Noguchi T, Shinohara K, Yukawa S, Inoue H, Ikeda T. Emerg Infect Dis, 2022; 28: 8 1569–77

Risk factors of breakthrough aspergillosis in lung transplant recipients receiving itraconazole prophylaxis. Katada Y, Nakagawa S, Nagao M, Yoshida Y, Matsuda Y, Yamamoto Y, Itohara K, Imai S, Yonezawa A, Nakagawa T, Matsubara K, Tanaka S, Nakajima D, Date H, Terada T. J Infect Chemother, 2022; 28: 1 54-60

Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan. Oka K, Matsumoto A, Tetsuka N, Morioka H, Iguchi M, Ishiguro N, Nagamori T, Takahashi S, Saito N, Tokuda K, Igari H, Fujikura Y, Kato H, Kanai S, Kusama F, Iwasaki H, Furuhashi K, Baba H, Nagao M, Nakanishi M, Kasahara K, Kakeya H, Chikumi H, Ohge H, Azuma M, Tauchi H, Shimono N, Hamada Y, Takajo I, Nakata H, Kawamura H, Fujita J, Yagi T; Japan Infection Prevention and Control Conference for National and Public University Hospitals. J Glob Antimicrob Resist, 2022; 29: 247-252.

Whole-Genome Analysis-Based Phylogeographic Investigation of Streptococcus pneumoniae Serotype 19A Sequence Type 320 Isolates in Japan. Nakano S, Fujisawa T, Chang B, Ito Y, Akeda H, Fujita J, Matsumura Y, Yamamoto M, Suga S, Oishi K, Nagao M, Ohnishi M. Antimicrob Agents Chemother, 2022; 66：2e0139521

Outcome After Lung Transplantation From a Donor With Bacterial Pneumonia Under the Japanese Donor Evaluation System. Tanaka S, Kayawake H, Yamada Y, Yutaka Y, Ohsumi A, Nakajima D, Hamaji M, Menju T, Yamamoto M, Nagao M, Date H. Transplant Proc, 2022; 54: 3 782-788

Analysis of a city-wide COVID-19 prevention strategy for aged-care facilities during third and fifth waves of COVID-19 in Kyoto City, Kyoto, Japan. Nagao M, Matsumura Y, Yamamoto M, Shinohara K, Yukawa S, Noguchi T, Tsuchido Y, Ikeda T. Influenza Other Respir Viruses, 2022; 16: 4 690-695

High mortality and morbidity among vaccinated residents infected with the SARS-CoV-2 Omicron variant during an outbreak in a nursing home in Kyoto City, Japan. Matsumura Y, Yamamoto M, Shinohara K, Tsuchido Y, Yukawa S, Noguchi T, Ikeda T, Nagao M. Am J Infect Control, S0196-6553: 22 675-677, 2022.

Non-invasive ventilation using a novel ventilator and non-vented full-face mask for patients with respiratory failure during the COVID-19 pandemic: Report of three cases. Minami T, Kai S, Tanaka T, Ito I, Kato G, Nagao M, Date H, Hirai T, Ohtsuru S, Chin K. Respir Investig, 60: 4 607-611, 2022.